Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by CMHarring218431on Jan 22, 2025 3:15pm
161 Views
Post# 36415683

RE:RE:RE:RE:Let me state the obvious

RE:RE:RE:RE:Let me state the obvious Thanks Canadafan
I stand corrected on many fronts today especially when I interpreted market sentiment to be not impressed. Should have allowed investors to digest the importance of the release and wait for the left coast to wake up. The two articles that I did copy and paste mid morning emphasizes what is evolving here and helps put more and more eyes on our little company. The volume is impressive. With that said anyone care to speculate on a close today. With conference tomorrow.... I believe it will spike up as traders sense no need to take a little profit
<< Previous
Bullboard Posts
Next >>